Patients with CRC with high levels of TRIM25 and EZH2 had the shortest overall survival (P < 0.001, Supplementary Fig. S1c) and disease-free survival (P < 0.001, Fig. 4H) compared with patients with low TRIM25 or low EZH2 levels. This evidence concerns the gene EZH2 and colorectal carcinoma.